▲ +0.50% Upside Potential
This price target is based on 12 analysts offering 12 month price targets for Livent in the last 3 months. The average price target is $17.91, with a high forecast of $24.00 and a low forecast of $7.50. The average price target represents a 0.50% upside from the last price of $17.82.
The current consensus among 12 polled investment analysts is to hold stock in Livent. This Hold consensus rating has held steady for over two years.
Livent Corporation manufactures and sells performance lithium compounds primarily used in lithium-based batteries, specialty polymers, and chemical synthesis applications in North America, Latin America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers lithium compounds for use in applications that have specific performance requirements, including battery-grade lithium hydroxide for use in high performance lithium-ion batteries; and butyllithium, which is used in the production of polymers and pharmaceutical products, as well as a range of specialty lithium compounds, including high purity lithium metal, which is used in the production of lightweight materials for aerospace applications and non-rechargeable batteries. It also provides lithium phosphate, pharmaceutical-grade lithium carbonate, high purity lithium chloride, and specialty organics; and lithium carbonate and lithium chloride for use as feedstock in the process of producing performance lithium compounds. The company was incorporated in 2018 and is headquartered in Philadelphia, Pennsylvania.